Marshall Wace
ROIV icon

Marshall Wace’s Roivant Sciences ROIV Stock Holding History

Marshall Wace’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.3M Sell
1,421,478
-825,465
-37% -$24.4M 0.04% 380
2026
Q1 		$62.2M Sell
2,246,943
-1,211,983
-35% -$31.1M 0.06% 289
2025
Q4 		$75.1M Sell
3,458,926
-519,075
-13% -$10.2M 0.07% 241
2025
Q3 		$60.2M Buy
3,978,001
+3,022,851
+316% +$37.4M 0.06% 273
2025
Q2 		$10.8M Buy
955,150
+683,327
+251% +$7.41M 0.01% 811
2025
Q1 		$2.74M Sell
271,823
-2,675,131
-91% -$28.9M ﹤0.01% 1332
2024
Q4 		$34.9M Buy
2,946,954
+1,505,062
+104% +$17.8M 0.04% 374
2024
Q3 		$16.6M Buy
1,441,892
+727,132
+102% +$8.28M 0.02% 573
2024
Q2 		$7.56M Buy
714,760
+660,660
+1,221% +$7.24M 0.01% 845
2024
Q1 		$570K Sell
54,100
-182,743
-77% -$1.97M ﹤0.01% 1881
2023
Q4 		$2.66M Buy
+236,843
New +$2.31M ﹤0.01% 1111
2023
Q3 		– Sell
-1,392,906
Closed -$14M – 2605
2023
Q2 		$14M Buy
1,392,906
+1,093,255
+365% +$9.78M 0.03% 607
2023
Q1 		$2.21M Buy
299,651
+250,670
+512% +$2.06M ﹤0.01% 1402
2022
Q4 		$391K Sell
48,981
-94,432
-66% -$525K ﹤0.01% 2466
2022
Q3 		$461K Buy
+143,413
New +$555K ﹤0.01% 2773

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Marshall Wace's ROIV Position: Q2 2026 in Review

Marshall Wace reduced its Roivant Sciences (ROIV) stake by 37% in Q2 2026, selling an estimated $24.4M and leaving 1,421,478 shares worth $50.3M. The position accounts for 0.04% of the portfolio, ranked #380.

Marshall Wace first reported a position in ROIV in Q3 2022 and has held it in 15 quarters since. The position peaked at $75.1M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Marshall Wace held 1,421,478 shares of Roivant Sciences worth $50.3M as of Q2 2026.
  • Marshall Wace sold 825,465 Roivant Sciences shares in Q2 2026, an estimated $24.4M.
  • Roivant Sciences made up 0.04% of Marshall Wace's portfolio in Q2 2026, its #380 holding.
  • Marshall Wace first reported a position in Roivant Sciences in Q3 2022 and has held it in 15 quarters since.
  • Marshall Wace's Roivant Sciences position peaked at $75.1M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.